FDA
Home Page | CDRH Home Page | Search
| CDRH
A-Z Index | Contact CDRH
|
To: | Jennie Butler, Chief, Dockets Management Branch |
From: | Linda Kahan, Deputy Director for Regulations and Policy, CDRH |
Re: | Extension of comment period for Docket No. 03N-0169 |
The Food and Drug Administration (FDA), Center for Devices and Radiological Health, is extending the comment period for Dental Amalgam; Request for Information (68 FR 25407) by 29 days to July 1, 2003. The Notice, published in the Federal Register on May 9, 2003, requested information about peer-reviewed journal articles that address human health risks from dental amalgam by June 1, 2003. In order to allow interested persons additional time to submit information, FDA is granting an extension of the comment period for Docket No. 03N-0169.
Updated 5/21/03
CDRH Home Page | CDRH A-Z Index | Contact CDRH | Accessibility | Disclaimer
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | HHS Home Page
Center for Devices and Radiological Health / CDRH